A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Science

• Publication date

  2011-08-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/science.1205669PMID 21798894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influenza virus assembly and budding.

  2011cited by this paper
• Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

  2011cited by this paper
• Helical peptide arrays for lead identification and interaction site mapping.

  2011cited by this paper
• Cleavage of Influenza Virus Hemagglutinin by Airway Proteases TMPRSS2 and HAT Differs in Subcellular Localization and Susceptibility to Protease Inhibitors

  2010cited by this paper
• Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins

  2010cited by this paper
• Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

  2010cited by this paper
• Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins

  2010cited by this paper
• Structural organization of a filamentous influenza A virus

  2010cited by this paper
• Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

  2009cited by this paper
• Antibody Recognition of a Highly Conserved Influenza Virus Epitope

  2009cited by this paper
• Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses

  2009cited by this paper
• Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

  2008cited by this paper
• Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion

  2008cited by this paper
• Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

  2008cited by this paper
• The Global Circulation of Seasonal Influenza A (H3N2) Viruses

  2008cited by this paper
• Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

  2008cited by this paper
• Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.

  2008cited by this paper
• Dendroscope: An interactive viewer for large phylogenetic trees

  2007cited by this paper
• A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies

  2007cited by this paper
• Fc receptor but not complement binding is important in antibody protection against HIV

  2007cited by this paper
• Variation and infectivity neutralization in influenza

  2006cited by this paper
• Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity

  2006cited by this paper
• Rapid and Quantitative Cyclization of Multiple Peptide Loops onto Synthetic Scaffolds for Structural Mimicry of Protein Surfaces

  2005cited by this paper
• H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes.

  2004cited by this paper
• IMGT, the international ImMunoGeneTics information system®

  2004cited by this paper
• IMGT®, the international ImMunoGeneTics information system®

  2004cited by this paper
• Plasma Cell Survival Is Mediated by Synergistic Effects of Cytokines and Adhesion-Dependent Signals1

  2003cited by this paper
• An antibody that prevents the hemagglutinin low pH fusogenic transition.

  2002cited by this paper
• Correlating overrepresented upstream motifs to gene expression: a computational approach to regulatory element discovery in eukaryotes

  2002cited by this paper
• H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes

  2002cited by this paper
• Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

  2000cited by this paper
• A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site

  1999cited by this paper
• Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays

  1999cited by this paper
• Understanding influenza virus pathogenicity.

  1999cited by this paper
• Membrane fusion by surrogate receptor-bound influenza haemagglutinin.

  1999cited by this paper
• Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus

  1997cited by this paper
• Structure of influenza haemagglutinin at the pH of membrane fusion

  1994cited by this paper
• Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs.

  1994cited by this paper
• A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains

  1993cited by this paper
• Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity.

  1992cited by this paper
• Evolution and ecology of influenza A viruses

  1992cited by this paper
• Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses.

  1991cited by this paper
• Structure and composition of influenza virus. A small-angle neutron scattering study.

  1985cited by this paper

• Panzootic H5 influenza viruses acquired resistance to human head interface antibodies.

  2026cites this paper
• Optimizing broadly neutralizing antibodies via all-atom interaction modeling and pre-trained language models

  2026cites this paper
• Decoding Protein Glycosylation for Better Vaccine and Antibody Development.

  2026cites this paper
• Pre-existing neutralizing antibodies against cattle-transmitted influenza A virus H5N1 are detectable in unexposed individuals.

  2026cites this paper
• Enhancing the breadth of protection in mice with a multivalent influenza vaccine

  2026cites this paper
• Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

  2026cites this paper
• Broadly neutralizing monoclonal antibodies against influenza A viruses: current insights and future directions

  2026cites this paper
• Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodies

  2026cites this paper
• Live-cell single-vRNP imaging identifies viral gene expression signatures that shape influenza infection heterogeneity.

  2026cites this paper
• A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine.

  2026cites this paper
• Epitope-spanning antigenic variation reprograms immunodominance and broadens immunity in sequential influenza vaccination.

  2026cites this paper
• Plant-Produced Broadly Neutralizing Influenza Monoclonal Antibody CR9114 Exhibits Activity Against Heterologous Avian Influenza Viruses

  2026cites this paper
• Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response.

  2025cites this paper
• Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus

  2025cites this paper
• Structural basis for a potent human neutralizing antibody targeting a conserved epitope on the H7 hemagglutinin head.

  2025cites this paper
• Resistance Mutations to Broadly Neutralizing Antibodies Destabilize Hemagglutinin and Attenuate H1N1 Influenza Virus

  2025cites this paper
• Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity

  2025influential citation
• Improved efficacy of an influenza DNA vaccine through high-density microarray patch delivery

  2025cites this paper
• Antiviral activity of mRNAS encoding intracellular scFv antibodies against conserved influenza virus epitopes

  2025cites this paper
• Childhood immunological imprinting of cross-subtype antibodies targeting the hemagglutinin head domain of influenza viruses

  2025cites this paper
• Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3

  2025cites this paper
• Molecular divergence and convergence of mammalian antibody responses to the influenza virus hemagglutinin stem.

  2025cites this paper
• How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza

  2025cites this paper
• An influenza HA mRNA-LNP vaccine induces potent responses in newborn nonhuman primates that enhance protection from challenge

  2025cites this paper
• Targeted Elimination of Influenza Virus and Infected Cells with Near-Infrared Antiviral Photoimmunotherapy (NIR-AVPIT)

  2025cites this paper
• A Broadly Conserved Protective Epitope on the Lyme Disease Vaccine Antigen, OspA

  2025cites this paper
• Term immune memory responses to human papillomavirus (HPV) vaccination following 2 versus 3 doses of HPV vaccine.

  2025cites this paper
• Knockin’ on Cell’s Door: Influenza A Virus Adsorption and Its Pharmacological Inhibition

  2025cites this paper
• A single mutation at position 214 of influenza B hemagglutinin enhances cross-neutralization

  2025cites this paper
• A replicating recombinant vesicular stomatitis virus model for dairy cattle H5N1 influenza virus glycoprotein evolution

  2025cites this paper
• The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody.

  2025cites this paper
• De novo design of D-peptide ligands: Application to influenza virus hemagglutinin

  2025cites this paper
• Subtype-specific neutralizing antibodies promote antigenic shift during influenza virus co-infection

  2025cites this paper
• Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses

  2025cites this paper
• Computational design and improvement of a broad influenza virus HA stem targeting antibody.

  2025cites this paper
• Bioorthogonal optimized virus immuno-nanomedicine (BOVIN)

  2025cites this paper
• Antigenic variability and conserved epitopes in influenza: Challenges and opportunities for universal vaccine design

  2025cites this paper
• Protective activity of CR9114 universal antibody isotypes against influenza A virus in vivo

  2025cites this paper
• Research Progress of Universal Influenza Vaccine

  2025cites this paper
• Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses

  2025cites this paper
• Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel

  2025cites this paper
• Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodies and overcomes immune imprinting patterns

  2025cites this paper
• Development of a broad-spectrum subunit vaccine against H9N2 avian influenza using HA stem domain scaffold and snoopligase system

  2025cites this paper
• Isolation of genetically diverse influenza antibodies highlights the role of IG germline gene variation and informs the design of population-comprehensive vaccine strategies

  2025cites this paper
• Maturation of human early-minted blood antibody-secreting cells is coupled with increased IgG secretion rates

  2025cites this paper
• Novel Mini‐Hemagglutinin Subunit Vaccine Induces Robust Mucosal and Systemic Immunity and Protection Against a Lethal Challenge With the H1N1 and H5N1 Influenza Viruses in Mice

  2025cites this paper
• Qualification of a reporter virus microneutralization assay for evaluation of influenza specific antibodies in human clinical trials.

  2025cites this paper
• Structure basis for distinct protective mechanisms of IGHV3-23 antibodies targeting influenza hemagglutinin stem

  2025cites this paper
• VHH antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusion

  2025cites this paper
• Improved cross-protection and immunity against influenza A virus in mice using a novel mRNA vaccine with optimized design of RNA sequence

  2025cites this paper
• Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutinin

  2025cites this paper
• Production and functional activity of scFv fragments obtained from recombinant antibodies against influenza virus

  2025cites this paper
• Regulated microbe vaccines: from concept to (pre-clinical) reduction to practice

  2025cites this paper
• Computationally designed stem-epitope mimetics elicit broadly reactive antibodies

  2025cites this paper
• Pre-exposure antibody prophylaxis protects macaques from severe influenza.

  2025cites this paper
• Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination

  2025cites this paper
• La Sota-vectored recombinant vaccine with chimeric hemagglutinin-neuraminidase for enhanced protection against highly pathogenic pigeon paramyxovirus type 1

  2025cites this paper
• Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genes

  2025cites this paper
• The Design and Prospects of Influenza Virus Vaccines Based on Conserved Epitopes and Adjuvant Optimization

  2025cites this paper
• Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches

  2025cites this paper
• Repeated COVID-19 vaccine boosters elicit variant-specific memory B cells in humans

  2025cites this paper
• Distinct binding modes drive the broad neutralization profile of two persistent influenza hemagglutinin stem-specific antibody lineages.

  2025cites this paper
• A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses

  2025cites this paper
• Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelope.

  2025cites this paper
• Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection

  2025cites this paper
• Making Universal Vaccines and Antibodies Through Glycoengineering.

  2025cites this paper
• Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies

  2025cites this paper
• Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle

  2025influential citation
• A Modular Mathematical Model of the Immune Response for Investigating the Pathogenesis of Infectious Diseases

  2025cites this paper
• An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses

  2025cites this paper
• A modular platform to display multiple hemagglutinin subtypes on a single immunogen

  2025cites this paper
• A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface

  2025cites this paper
• Guided design for the development of an evolution-proof influenza vaccine.

  2025cites this paper
• Divergent antibody-mediated population immunity to H5, H7 and H9 subtype potential pandemic influenza viruses

  2025cites this paper
• A replicating recombinant vesicular stomatitis virus model for dairy cattle H5N1 influenza virus glycoprotein evolution

  2025cites this paper
• High-throughput synthesis and specificity characterization of natively paired antibodies using oPool+ display

  2024cites this paper
• Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus

  2024cites this paper
• Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses

  2024cites this paper
• Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement

  2024cites this paper
• Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States

  2024cites this paper
• Adeno-associated viral vectors deliver gene vaccines.

  2024cites this paper
• Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza

  2024cites this paper
• Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

  2024influential citation
• Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes

  2024cites this paper
• Monoclonal antibodies: From magic bullet to precision weapon

  2024cites this paper
• Prospects of universal influenza virus vaccine and the current challenges of new antiviral drugs

  2024cites this paper
• Disulfide-stabilized trimeric hemagglutinin ectodomains provide enhanced heterologous influenza protection

  2024cites this paper
• Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen

  2024cites this paper
• Maturation of germinal center B cells after influenza virus vaccination in humans

  2024cites this paper
• mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents influenza virus infection in vitro.

  2024cites this paper
• Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem

  2024cites this paper
• The D Gene in CDR H3 Determines a Public Class of Human Antibodies to SARS-CoV-2

  2024cites this paper
• Opportunities and challenges for T cell-based influenza vaccines

  2024cites this paper
• Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift

  2024cites this paper
• A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain VL and an RNA hydrolyzing scFv

  2024cites this paper
• The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines

  2024cites this paper
• Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses

  2024cites this paper
• Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head

  2024cites this paper
• Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase.

  2024cites this paper
• Mosaic quadrivalent influenza vaccine single nanoparticle characterization

  2024cites this paper